Analyst Price Target is $5.00
▲ +112.77% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Xenetic Biosciences in the last 3 months. The average price target is $5.00, with a high forecast of $5.00 and a low forecast of $5.00. The average price target represents a 112.77% upside from the last price of $2.35.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Xenetic Biosciences.